The Science Behind Mpox Response

Enroll


Description

APHL in partnership with the Association for Molecular Pathology (AMP) is convening this webinar to provide information on the laboratory response to the current outbreak of Mpox virus. Speakers will address the current state of the response, the science of poxviruses such as Mpox, the development and use of laboratory tests for diagnoses as well as biosafety considerations for testing.

Learning Objectives

  • Describe the current state of mpox response in the United States, including current public health emergency declarations
  • Summarize the science of mpox virus
  • Describe the impact of public health emergency declarations on testing and key principles for implementing tests in a clinical setting 
  • Identify biosafety practices for working with mpox virus and other pathogens
  • Summarize the identification of the first case of mpox virus in the US (2022) and the importance of laboratory testing 

Speakers

Alexander L. Greninger, MD, PhD., MS, M.Phil.
Assistant director, University of Washington Medicine Clinical Virology Laboratory, Assistant Professor, Laboratory Medicine

Christina Hutson, Ph.D., MS.
Branch chief, Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention

Jonathan Mermin, MD, MPH.
Incident manager, Monkeypox Response, Director of the National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Rear Admiral, U,S, Public Health Service

Sandra C. Smole, PhD.
Director, Massachusetts State Public Health Laboratory, Bureau of Infectious Disease and Laboratory Sciences, Department of Public Health

Timothy Stenzel, MD, PhD.
Director, Office of In Vitro Diagnostics and Radiological Health, U.S. Food and Drug Administration

Moderators

Allen Bateman, Ph.D., D (ABMM) 
Association of Molecular Pathology Directors, director, Communicable Disease Division, Wisconsin State Laboratory of Hygiene

Andrew C. Cannons, Ph.D., HCLD (ABB)
Chair, Public Health Preparedness and Response Committee, APHL, laboratory director, Bureau of Public Health Laboratories –Tampa, Division of Disease Control and Health Protection, Florida Department of Health

Duration: 60 minutes
Level of instruction: Basic
Recorded: December 20, 2022
Level of Instruction: Basic

Enroll